{"id":"W2566007460","doi":"10.1182/blood.v118.21.573.573","title":"Reinduction Chemoimmunotherapy with Epratuzumab in Relapsed Acute Lymphoblastic Leukemia (ALL) in Children, Adolescents and Young Adults: Results From Children's Oncology Group (COG) Study ADVL04P2","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Cog; Medicine; Chemoimmunotherapy; Oncology; Internal medicine; Clinical endpoint; Chemotherapy; Clinical trial; Cyclophosphamide","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002226224,0.0004069737,0.001451353,0.0003683485,0.0002268637,0.0006258904,0.0004336774,0.0005955833,0.0006184145],"category_scores_gemma":[0.001341794,0.0002849585,0.001173691,0.0005830356,0.0003852324,0.0003480293,0.0003420429,0.001267643,0.0002195109],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007069494,"about_ca_system_score_gemma":0.001108667,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002240769,"about_ca_topic_score_gemma":0.002831128,"domain_scores_codex":[0.9991925,0.000466016,0.00006224549,0.00006832451,0.0001161867,0.00009471718],"domain_scores_gemma":[0.9985996,0.0003774365,0.0003719827,0.0001237486,0.0001078312,0.0004193143],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4259346,0.03130044,0.2988547,0.00127349,0.004173578,0.0008352682,0.00128864,0.002249538,0.01301202,0.0003144846,0.004963914,0.2157993],"study_design_scores_gemma":[0.09304921,0.3692281,0.516888,0.0002385584,0.004169173,0.001170371,0.0003463082,0.0007964082,0.004288309,0.000108318,0.009664583,0.00005252255],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9959662,0.002799511,0.00006270556,0.0001172087,0.00002001348,0.0002133139,0.0003915625,0.00001056729,0.0004189194],"genre_scores_gemma":[0.9933657,0.003438927,0.0004634869,0.0004731822,0.00008375489,0.0003971235,0.001376424,0.000009840744,0.0003915976],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002240769,"threshold_uncertainty_score":0.01177353,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01370997402574401,"score_gpt":0.2540233162947987,"score_spread":0.2403133422690547,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}